Humanized antibody molecules to CD138 and uses thereof
MYPI2025003431A0Undetermined Publication Date: 2020-12-17VISTERRA INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025003431
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2020-06-05
- Filing Date
- 2020-06-17
- Publication Date
- 2020-12-17
Abstract
Humanized antibody molecules that specifically bind to CD138 are disclosed. The humanized antibody molecules can be used to treat, prevent, and / or diagnose disorders, such as multiple myeloma. Fig. 1
Need to check novelty before this filing date? Find Prior Art
